| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Jeffrey M. Dayno
Also a director
President and Chief Executive Officer
|
68 |
Since 2023
3 years
|
$7,899,535 | |
|
Peter Anastasiou
President and Chief Executive Officer
|
55 | Not stated | Not reported | |
|
Stephen Mollichella
Interim Principal Financial Officer
Title from the Form 8-K dated Jul 16, 2026
|
Not stated | Not stated | Not reported | |
|
Andrew Serafin
Chief Strategy Officer
|
51 |
Since 2021
5 years
|
$2,009,277 | |
|
Kumar Budur
Chief Medical Officer
|
55 |
Since 2023
3 years
|
$2,279,439 | |
|
Adam Zaeske
Chief Commercial Officer
|
53 |
Since 2025
1 year
|
$3,664,228 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 3, 2026 · updated by the 8-K of Oct 13, 2026
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 3, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...